Zhangzhou Pientzehuang Pharmaceutical., Ltd

Symbol: 600436.SS

SHH

216.58

CNY

Market price today

  • 48.0057

    P/E Ratio

  • 0.4243

    PEG Ratio

  • 130.67B

    MRK Cap

  • 0.01%

    DIV Yield

Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436-SS) Financial Statements

On the chart you can see the default numbers in dynamics for Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS). Companys revenue shows the average of 2562.636 M which is 0.176 % gowth. The average gross profit for the whole period is 1412.694 M which is 0.202 %. The average gross profit ratio is 0.514 %. The net income growth for the company last year performance is 0.126 % which equals 0.200 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Zhangzhou Pientzehuang Pharmaceutical., Ltd, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.174. Long-term investments of the company, while not its focus, stand at 0, if any, in the reporting currency. This indicates a difference of -100.000% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 0 in the reporting currency. This figure signifies a year_over_year change of -1.000%. Shareholder value, as depicted by the total shareholder equity, is valued at 13363.262 in the reporting currency. The year over year change in this aspect is 0.179%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 0, with an inventory valuation of 0, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 0.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

balance-sheet.row.cash-and-short-term-investments

8419.2702496.47105.6
5168.5
4263.4
2786.6
2117.1
1706.3
1471.6
1251.5
1182.6
413.3
350
227.9
245.5
163
219.3
257.9
281.2
257.6
323.6
83.3
26.6
6

balance-sheet.row.short-term-investments

-153.2406276.18.8
0
0
0
0
0.1
-48.5
-48
0
0
0
0.1
5
0
0
2.5
7.5
16.8
126.9
0
0
0

balance-sheet.row.net-receivables

3554.8101298.5984.2
809.6
880.4
706.3
801.3
529.9
462
220.6
317.3
259.1
171.4
161
187
189.9
144.6
137.5
86.1
58.6
48.3
95.5
144.5
189.5

balance-sheet.row.inventory

8047.1302627.82437.5
2190.9
2097
1667.5
1242.8
1126
878.4
890.4
753.6
560.5
369.1
335.9
333.1
295.9
204.3
154.3
135.9
88.6
109.5
103.8
91.6
76.5

balance-sheet.row.other-current-assets

21242.2806282106.1
127
111.5
69.7
56.9
50.2
11.7
10.6
-3.3
-15.3
-1.9
-2.9
-13.5
-14.8
-18.6
-18.2
-13.2
-13.1
-3.7
-30.1
-59.5
-75.4

balance-sheet.row.total-current-assets

41263.49012704.810633.4
8296
7352.3
5230.1
4218.2
3412.4
2823.7
2373.1
2250.3
1217.5
888.6
721.9
752.1
634
549.5
531.6
490.1
391.7
477.6
252.5
203.3
196.6

balance-sheet.row.property-plant-equipment-net

1486.390454387.8
261.8
240.7
236.1
248.9
256.7
271
284
277.8
238.2
195.7
180
188.4
167.7
158.9
85.4
92.3
84.6
83
68.4
67.1
62.1

balance-sheet.row.goodwill

0000
0
0
6.1
41.6
20.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

928.710319.4221
259.4
155.7
121.1
173.9
293.4
164.5
166.8
125.7
92.9
58.8
63.2
48
43.9
39.1
16.8
17
0.2
0.2
0.3
0
0

balance-sheet.row.goodwill-and-intangible-assets

928.710319.4221
259.4
155.7
127.2
215.5
314.2
164.5
166.8
125.7
92.9
58.8
63.2
48
43.9
39.1
16.8
17
0.2
0.2
0.3
0
0

balance-sheet.row.long-term-investments

2148.990696.8791.1
979.2
896.2
893.5
830.3
900
680.7
753.1
543.2
0
384.2
445.5
281.2
0
0
94.2
86.7
65.5
-92.7
0
0
0

balance-sheet.row.tax-assets

545.180167.3141.2
85.4
76.2
64.3
40.8
33.4
26.9
17.6
13.4
11.2
10
7.3
6.3
5.4
1.8
0
7.7
0
0
0
0
0

balance-sheet.row.other-non-current-assets

697.940261.5320.9
323.8
89.7
106.6
94.6
121.1
88.2
55.1
48.8
670.9
31.5
28.9
8.5
219.4
221.7
2.5
-0.2
16.8
126.9
4.6
0
0

balance-sheet.row.total-non-current-assets

5807.22018991861.9
1909.5
1458.5
1427.7
1430.1
1625.4
1231.2
1276.5
1009
1013.2
680.1
724.9
532.5
436.5
421.4
199
203.5
167.1
117.3
73.3
67.1
62.1

balance-sheet.row.other-assets

17140.9417140.900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

64211.6517140.914603.812495.3
10205.6
8810.8
6657.8
5648.3
5037.8
4054.9
3649.6
3259.3
2230.8
1568.7
1446.8
1284.5
1070.5
970.9
730.6
693.6
558.8
595
325.8
270.4
258.7

balance-sheet.row.account-payables

1311.260466.5387.7
240.7
260.8
250.1
222.1
224
90.6
78
76.3
79.6
67
97.3
78.4
81.4
86.5
68.8
50
1.1
3.5
17.8
2.2
0.7

balance-sheet.row.short-term-debt

2697.9601000.2798.5
718.4
696.8
599.6
466.9
350.9
56.3
0
52.6
48.2
142.6
87.5
212.6
170
72
4
9
0
0
10
35
10

balance-sheet.row.tax-payables

746.720107.8136.1
133.9
246.9
88
55.6
27.6
72
48.2
62.1
22.8
26.7
18.8
6.5
-3.5
-10.6
7.3
2.7
10.2
11.7
52.5
48.1
32.2

balance-sheet.row.long-term-debt-total

348.230108.886.7
29.4
29
24.8
0.2
299.9
299.2
298.6
298
314
0
30
20
0
0
10.8
9.1
0
0
20
0
0

Deferred Revenue Non Current

51.3401720.2
14.7
14.7
18.1
17.7
18.3
19.8
19.2
15.5
9.4
0
9.4
9.4
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

172.83---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

726.650565.537.8
32.3
201.8
352
107.3
53.4
30.3
175.6
24.2
18.8
23.7
16.9
20.1
6.9
7.3
2.9
0.7
18.1
37.4
2.6
1.2
8.1

balance-sheet.row.total-non-current-liabilities

811.280269.7221.5
148.7
94
60.4
71.6
377
389.7
408.7
380
412.4
70.4
113.9
75.5
22.6
32
11.9
9.7
0.5
0.6
21.4
0.9
0.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

299.370108.886.7
106.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

8211.9202779.92358.6
1949
1841
1350.1
1223
1287.1
751.6
662.3
667.1
675.2
379.7
363
427.4
318.4
212
109.5
85.6
19.7
41.4
171
124.3
117.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

2413.27603.3603.3603.3
603.3
603.3
603.3
603.3
603.3
402.2
160.9
160.9
140
140
140
140
140
140
140
140
140
140
100
100
100

balance-sheet.row.retained-earnings

27823.0808205.46699
4976.6
4000.6
3117.1
2345.8
1780.9
1440.1
1163.5
956.1
677.8
459.6
326
219.6
178.7
120.9
78.3
73.7
36.8
60.1
8.7
8.7
11.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

6569.8701475.21364.3
1244.5
990.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

13806.0412759.91046.11038.4
1037.7
1036.6
1296.1
1187
1109.2
1313.1
1584
1389.2
682.4
551.7
583.5
465
407.4
462.2
371.8
364.6
351.5
342.8
46.2
37.3
29.5

balance-sheet.row.total-stockholders-equity

50612.2513363.3113309705
7862.2
6631.4
5016.5
4136
3493.4
3155.4
2908.4
2506.2
1500.2
1151.3
1049.5
824.6
726.2
723.1
590.1
578.3
528.3
542.9
154.8
146
141.4

balance-sheet.row.total-liabilities-and-stockholders-equity

47070.71014603.812495.3
10205.6
8810.8
6657.8
5648.3
5037.8
4054.9
3649.6
3259.3
2230.8
1568.7
1446.8
1284.5
1070.5
970.9
730.6
693.6
558.8
595
325.8
270.4
258.7

balance-sheet.row.minority-interest

1609.80494431.7
394.4
338.4
291.1
289.2
257.3
147.9
78.9
86
55.3
37.7
34.4
32.6
25.9
35.7
31
29.7
10.7
10.7
0
0
0

balance-sheet.row.total-equity

52222.0513363.311823.910136.7
8256.6
6969.8
5307.6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

47070.71---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

1995.760673.7799.9
979.2
896.2
893.5
830.3
900.1
632.2
705
543.3
635.3
384.2
445.5
286.3
216.4
219.6
96.7
94.3
82.3
34.2
4.6
0
0

balance-sheet.row.total-debt

3046.1901109885.2
718.4
696.8
599.6
466.9
650.7
355.5
298.6
350.6
362.3
142.6
117.5
232.6
170
72
4
9
0
0
30
35
10

balance-sheet.row.net-debt

-5373.080-1387.5-6211.6
-4450.1
-3566.5
-2186.9
-1650.2
-1055.4
-1116.1
-953
-832
-51
-207.4
-110.3
-7.9
7
-147.3
-251.5
-264.7
-240.8
-196.7
-53.3
8.4
4

Cash Flow Statement

The financial landscape of Zhangzhou Pientzehuang Pharmaceutical., Ltd has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -1.000. The company recently extended its share capital by issuing 0, marking a difference of -0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 0 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to 0.000 in the reporting currency. This is a shift of 0.000 from the previous year. In the same period, the company recorded 0, 0, and 0, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 0, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

cash-flows.row.net-income

2724.262783.725232464
1689.4
1386.9
1128.7
780.4
506.8
463.3
437.9
431.1
350.6
256.5
194.7
130.3
141.7
96.4
83.8
87.2
41.9
60.6
58.8
52.2

cash-flows.row.depreciation-and-amortization

7.23080.4133.5
90.2
55.9
60.5
65.2
46.4
32.8
29.2
22.5
20.1
18.8
17.7
15.8
13.8
14
10.3
9.1
8.8
7.6
7.6
6.7

cash-flows.row.deferred-income-tax

009.3-58.2
-12.6
-8.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

00-9.358.2
12.6
8.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

004272.8-2175.9
-270.1
-2350
-547.8
-162.5
-195.1
-191.1
-160.4
-186.5
-192
-47.9
19.3
-20
-104.2
-35.1
-35.8
-17.2
5.6
-33
36.7
5.1

cash-flows.row.account-receivables

004257.8-2088.7
-222.1
-2073
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

00-199.4-261.6
-74.9
-429.6
-434.7
-108.1
-266.8
13.2
-135.4
-195.1
-191.3
-38.6
-2.8
-37.6
-91.6
-47
-18.4
-47.3
21
-2.1
-12.2
-15.1

cash-flows.row.account-payables

00205232.6
39.5
161
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

009.3-58.2
-12.6
-8.4
-113.2
-54.4
71.7
-204.4
-25.1
8.6
-0.6
-9.3
22.1
17.6
-12.6
11.9
-17.4
30.1
-15.4
-30.9
48.9
20.2

cash-flows.row.other-non-cash-items

-216.69-2783.7-3.140.7
-42.4
27.8
-29
-6.2
36.5
0.6
-42.2
7.3
-16.4
5.4
-26.3
3.4
-38.6
-15.3
-7.6
-10
42.3
-2.8
2.3
1.9

cash-flows.row.net-cash-provided-by-operating-activities

2514.79000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-99.330-175.4-92.2
-419
-65.4
-74.2
-51.9
-91
-78.9
-25.9
-146.5
-155.2
-35.6
-38.9
-29.7
-58.5
-106.5
-8.7
-34.5
-10.8
-15.6
-9.8
-11.6

cash-flows.row.acquisitions-net

0.84035.220.7
-1.9
13.2
0
-14.9
-3.2
-4.9
2.9
0
0.2
0.2
39.3
0.3
3.5
106.5
8.7
1.2
10.9
15.6
0
0

cash-flows.row.purchases-of-investments

-0.010-58.5-9.5
-14.2
-1
-54.2
-1.3
-352.7
-41.3
-21.6
0
-115.9
-20.7
-4.2
-5.2
-45.1
-61
-124.1
-269.2
-245.3
-253.1
-4.5
0

cash-flows.row.sales-maturities-of-investments

13.57045.4174.6
66.9
61.7
69.5
113.2
15.3
63.5
87.7
37.9
29.8
24.3
18
2.2
3.1
53.2
139.3
273.7
260.9
105.1
0
0

cash-flows.row.other-investing-activites

-1226.450-6151.5-15.4
86.2
59.3
124.1
18.1
153.2
22.8
1.1
-587.7
16.7
0.3
-38.9
-0.4
-1.4
-106.5
-8.7
0
-10.8
-15.6
0
0

cash-flows.row.net-cash-used-for-investing-activites

-1311.370-6304.878.3
-282
67.8
65.1
63.1
-278.3
-38.8
44.2
-696.3
-224.6
-31.3
-24.7
-32.7
-98.4
-114.2
6.5
-28.8
5
-163.5
-14.3
-11.6

cash-flows.row.debt-repayment

-985.350-1396-1355.6
-1062.2
-1065.1
-667.4
-800.6
-99.4
-8.7
-52.6
-170.8
-376.3
-154.2
-305.4
-395.1
-199
-105
-9
0
0
-40
-105
-45

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-773.570-760.6-569.2
-522.3
-392.6
-284.2
-197.1
-166.5
-160.7
-193.6
-130.4
-104.9
-103.7
-77.6
-84.1
-74.9
-62
-68.5
-34.3
-59.6
-50.8
-29
-58.4

cash-flows.row.other-financing-activites

825.3501580.81384.5
1048
1862.6
835.5
582.1
512.1
123.8
4.2
933
606
182.6
190.9
459.3
307
176.2
2.3
27.2
0
332.9
99.6
69.9

cash-flows.row.net-cash-used-provided-by-financing-activities

-933.570-575.8-540.2
-536.5
404.9
-116.1
-415.6
246.2
-45.6
-242
631.8
124.8
-75.3
-192.1
-19.9
33
9.2
-75.2
-7.1
-59.6
242.1
-34.4
-33.5

cash-flows.row.effect-of-forex-changes-on-cash

4.9011.4-4.6
-6.3
4.9
8.2
-2.2
7.1
0.8
0.2
-0.7
0.1
-1.3
-0.3
-0.1
-0.1
0
-0.2
-0.2
-0.1
-0.1
-0.1
-0.1

cash-flows.row.net-change-in-cash

139.4903.8-4.3
642.3
-401.8
569.5
322.3
369.6
221.9
66.8
209.1
62.7
125
-11.7
76.8
-52.9
-45
-18.2
32.9
44
110.8
56.7
20.6

cash-flows.row.cash-at-end-of-period

10832.572422.32411.52407.7
2412
1769.7
2171.5
1602
1279.7
910.1
688.2
621.3
412.3
349.5
224.5
236.2
159.4
212.3
255.5
273.7
240.8
196.7
83.3
26.6

cash-flows.row.cash-at-beginning-of-period

10693.082422.32407.72412
1769.7
2171.5
1602
1279.7
910.1
688.2
621.3
412.3
349.5
224.5
236.2
159.4
212.3
257.4
273.7
240.8
196.7
86
26.6
6

cash-flows.row.operating-cash-flow

2514.7906873462.3
1467.1
-879.4
612.3
676.9
394.5
305.5
264.5
274.3
162.4
233
205.4
129.5
12.6
60
50.7
69.1
98.7
32.4
105.4
65.8

cash-flows.row.capital-expenditure

-99.330-175.4-92.2
-419
-65.4
-74.2
-51.9
-91
-78.9
-25.9
-146.5
-155.2
-35.6
-38.9
-29.7
-58.5
-106.5
-8.7
-34.5
-10.8
-15.6
-9.8
-11.6

cash-flows.row.free-cash-flow

2415.4606697.7370.1
1048.1
-944.8
538.1
625.1
303.6
226.6
238.6
127.8
7.2
197.4
166.5
99.9
-45.9
-46.4
42
34.5
87.9
16.8
95.7
54.2

Income Statement Row

Zhangzhou Pientzehuang Pharmaceutical., Ltd's revenue saw a change of 0.154% compared with the previous period. The gross profit of 600436.SS is reported to be 10034.63. The company's operating expenses are 6642.16, showing a change of 500.817% from the last year. The expenses for depreciation and amortization are 0, which is a 0.000% change from the last accounting period. Operating expenses are reported to be 6642.16, which shows a 500.817% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.140% year-over-year growth. The operating income is 3392.48, which shows a 0.140% change when compared to the previous year. The change in the net income is 0.126%. The net income for the last year was 2783.71.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

income-statement-row.row.total-revenue

10034.6310034.686948021.6
6510.8
5722.3
4766.2
3714
2309
1885.7
1453.9
1395.9
1171.2
1021.6
867.3
694.7
649.7
593.1
522.2
418.8
253.5
213.6
212
193.9
183.9

income-statement-row.row.cost-of-revenue

3917.4304725.93953
3570.6
3190.9
2744.4
2107.2
1178.8
999.3
728.2
634.2
551.3
556.4
533.1
430.4
408.2
375
332.3
215.1
83
70.4
74.5
70.9
65.6

income-statement-row.row.gross-profit

6117.210034.63968.14068.6
2940.2
2531.3
2021.8
1606.8
1130.1
886.4
725.7
761.7
619.8
465.2
334.2
264.3
241.5
218
189.9
203.7
170.5
143.2
137.5
123
118.4

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

180.2---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

260.46---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

378.14---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-1920.38-6642.2341.1376.3
293.7
258.1
7.5
-5.8
4.7
11.2
9.9
14
25.7
0.4
2.2
0.9
0.5
2.4
0.3
2.4
1.9
2.4
0.7
0.9
-2.9

income-statement-row.row.operating-expenses

2824.236642.21105.51291.1
1109.4
948
769.2
703.6
523
364.2
286.6
261.3
220.5
158.9
132.2
111.3
115
88.2
74
83.5
97.4
61.6
48
41.9
33.6

income-statement-row.row.cost-and-expenses

6741.666642.25831.45244.1
4680
4139
3513.6
2810.8
1701.8
1363.6
1014.8
895.5
771.8
715.3
665.2
541.7
523.2
463.3
406.4
298.6
180.4
132.1
122.5
112.8
99.2

income-statement-row.row.interest-income

-43.99096.4125.7
94
75
35.4
34.4
32.5
32.1
30.3
15.4
7.3
4
2.7
0
0
0
2.6
2.8
2.3
1.9
0.2
0.1
0.1

income-statement-row.row.interest-expense

27.8303832.9
27.4
31.1
27.6
24.1
27
18.1
19.8
21.5
19.7
7
7.6
6.1
2.8
0
0.7
0.1
0
0.8
1.9
1.4
0.9

income-statement-row.row.selling-and-marketing-expenses

378.14---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-25.85-25.82-5.5
1.8
6.4
74.9
38.4
2.1
27.6
78.5
9.1
15.9
-1.4
30.2
0.1
41.8
18.4
10.7
12.3
4.5
8
-1.6
-1.8
-3.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-1920.38-6642.2341.1376.3
293.7
258.1
7.5
-5.8
4.7
11.2
9.9
14
25.7
0.4
2.2
0.9
0.5
2.4
0.3
2.4
1.9
2.4
0.7
0.9
-2.9

income-statement-row.row.total-operating-expenses

-25.85-25.82-5.5
1.8
6.4
74.9
38.4
2.1
27.6
78.5
9.1
15.9
-1.4
30.2
0.1
41.8
18.4
10.7
12.3
4.5
8
-1.6
-1.8
-3.8

income-statement-row.row.interest-expense

27.8303832.9
27.4
31.1
27.6
24.1
27
18.1
19.8
21.5
19.7
7
7.6
6.1
2.8
0
0.7
0.1
0
0.8
1.9
1.4
0.9

income-statement-row.row.depreciation-and-amortization

37.960144.9171.5
95.2
103.8
60.5
65.2
46.4
32.8
29.2
22.5
20.1
18.8
17.7
15.8
13.8
14
10.3
9.1
8.8
7.6
7.6
6.7
-2.1

income-statement-row.row.ebitda-caps

3430.44---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

3392.483392.52975.72874.5
1977.1
1638.1
1320
947.4
608.5
541.6
508.2
496.7
390
305.3
231
152.6
168
147.2
126.5
132.1
77.1
89.4
88.9
81
84.1

income-statement-row.row.income-before-tax

3366.633366.62977.72869
1978.9
1644.6
1327.5
941.6
609.2
549.7
517.6
509.5
415.3
304.9
232.3
153.2
168.3
148.2
126.6
133.5
78.3
90.7
88.8
80.6
81

income-statement-row.row.income-tax-expense

582.92582.9454.8405
289.5
257.7
198.8
161.1
102.4
86.4
79.7
78.4
64.7
48.3
37.6
22.9
26.7
51.8
42.8
46.3
36.4
30.1
30
28.4
31

income-statement-row.row.net-income

2724.262783.72472.32431.9
1671.5
1374.4
1142.9
807
536.1
466.7
438.8
429.8
348.5
254.9
194.1
129.7
140.9
95.2
81.9
86.4
41.8
60.5
58.8
52.2
50.1

Frequently Asked Question

What is Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS) total assets?

Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS) total assets is 17140941100.000.

What is enterprise annual revenue?

The annual revenue is 4989357489.000.

What is firm profit margin?

Firm profit margin is 0.610.

What is company free cash flow?

The free cash flow is 4.000.

What is enterprise net profit margin?

The net profit margin is 0.271.

What is firm total revenue?

The total revenue is 0.338.

What is Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS) net profit (net income)?

The net profit (net income) is 2783705900.000.

What is firm total debt?

The total debt is 0.000.

What is operating expences number?

The operating expences are 6642157300.000.

What is company cash figure?

Enretprise cash is 0.000.